Drug information for TRI-NORINYL 21-DAY
Form
Dosage
Status
Therapeutic Equivalence
Active Ingred
Ref.
Sponsor
Document
TABLET; ORAL-21
0.035MG,0.035MG,0.035MG;0.5MG,1MG,0.5MG
Discontinued
ETHINYL ESTRADIOL
;
NORETHINDRONE
Norethindrone
WATSON LABS
18977
Drug Adverse Effects information for TRI-NORINYL 21-DAY
Role code
Indications
Reaction
# Reports
C
CONTRACEPTION
ARTHRALGIA
2
C
CONTRACEPTION
DEEP VEIN THROMBOSIS
2
C
CONTRACEPTION
MENTAL DISORDER
2
C
CONTRACEPTION
MUSCLE STRAIN
2
C
CONTRACEPTION
PAIN
2
Ads by Google